Yougui Yin attenuates adipogenic differentiation of bone marrow mesenchymal stem cells by modulating PPARγ pathway to treat glucocorticoid-induced osteonecrosis.
10.19540/j.cnki.cjcmm.20250307.401
- Author:
Hong-Zhong XI
1
;
Hao CHEN
1
;
Shuai HE
1
;
Wei SONG
1
;
Jia-Hao FU
1
;
Bin DU
1
;
Xin LIU
1
Author Information
1. Department of Orthopedics, Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China.
- Publication Type:Journal Article
- Keywords:
PPARγ;
Yougui Yin;
adipogenic differentiation;
glucocorticoid-associated osteonecrosis of the femoral head;
transplantation of bone marrow mesenchymal stem cells
- MeSH:
Animals;
Mesenchymal Stem Cells/metabolism*;
PPAR gamma/genetics*;
Rats;
Drugs, Chinese Herbal/administration & dosage*;
Male;
Glucocorticoids/adverse effects*;
Rats, Sprague-Dawley;
Adipogenesis/drug effects*;
Osteonecrosis/genetics*;
Cell Differentiation/drug effects*;
Bone Marrow Cells/metabolism*;
Femur Head Necrosis/chemically induced*;
Humans
- From:
China Journal of Chinese Materia Medica
2025;50(12):3356-3367
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to investigate the pharmacological effects and mechanisms of Yougui Yin in treating glucocorticoid-induced osteonecrosis. A rat model of glucocorticoid-associated osteonecrosis of the femoral head(GA-ONFH) was established by intramuscular injection of dexamethasone at 20 mg·kg~(-1) every other day for 8 weeks. Rats were randomly allocated into control, model, and low-and high-dose(1.5 and 3.0 g·kg~(-1), respectively) Yougui Yin groups. After modeling, rats in Yougui Yin groups were administrated with Yougui Yin via gavage, which was followed by femoral specimen collection. Hematoxylin-eosin staining was employed to observe femoral head repair, and immunofluorescence was employed to assess adipogenic differentiation of bone marrow mesenchymal stem cells(BMSCs) within the femoral head. Cell experiments were carried out with dexamethasone(1 μmol·L~(-1))-treated BMSCs to evaluate the effects of Yougui Yin-medicated serum on adipogenic differentiation. Animal experiments demonstrated that compared with the model group, Yougui Yin at both high and low doses significantly improved bone mineral density(BMD), bone volume/total volume(BV/TV) ratio, and trabecular thickness(Tb.Th) in the femoral head. Additionally, Yougui Yin alleviated necrosis-like changes and adipocyte infiltration and significantly reduced the expression level of peroxisome proliferator-activated receptor γ(PPARγ) in the femoral head, thereby suppressing the adipogenic differentiation of BMSCs in GA-ONFH rats. The cell experiments revealed that Yougui Yin-medicated serum markedly inhibited dexamethasone-induced adipogenic differentiation of BMSCs and down-regulated the level of PPARγ. The overexpression of PPARγ attenuated the inhibitory effect of Yougui Yin-medicated serum on the adipogenic differentiation of BMSCs, indicating the critical role of PPARγ in Yougui Yin-mediated suppression of adipogenic differentiation of BMSCs. In conclusion, Yougui Yin exerts therapeutic effects on glucocorticoid-induced osteonecrosis by down-regulating PPARγ expression and inhibiting adipogenic differentiation of BMSCs.
